tradingkey.logo

Morningstar does not foresee major changes in strategy, risk at PolyNovo under new CEO

ReutersMar 11, 2025 7:18 PM

Analysts at Morningstar do not see significant changes in strategy or risk at Australia's PolyNovo PNV.AX if it transitions to a new chief executive officer

The biotech firm said on Tuesday it has removed its CEO after discussions with the executive last week following media allegations about bullying by the firm's chairman directed at its chief

Brokerage says transition to a new CEO will be made easier given outgoing chief's efforts over his tenure of almost three years and the underlying business being left in a solid position

Says CEO Swami Raote oversaw a period of growth in the firm’s global operations, enabling Polynovo’s maiden profit in fiscal 2024

With the current board, there remains a risk of dysfunction among senior management, but also an opportunity to strengthen governance and the working environment - Morningstar

Stock down 43.4% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI